Ederer

Eder Therapeutics is a Canadian biotechnology company dedicated to developing and commercializing innovative treatments for rare diseases and cardiometabolic disorders. The company focuses on addressing unmet medical needs within the Canadian market while aiming to deliver domestic innovations to patients globally. Eder Therapeutics operates through a scalable model, leveraging strategic partnerships with leading research organizations and clinical networks to advance its pipeline. Their primary focus areas include dyslipidemia and related metabolic risks, with a commitment to fostering Canadian talent and cultural identity in the life sciences sector.